Abstract
Pregnane X receptor (PXR, NR1I2), a member of the nuclear receptor superfamily, is a crucial regulator of nutrient metabolism and metabolic detoxification such as metabolic syndrome, xenobiotic metabolism, inflammatory responses, glucose, cholesterol and lipid metabolism, and endocrine homeostasis. Notably, much experimental and clinical evidence show that PXR senses xenobiotics and triggers the detoxification response to prevent diseases such as diabetes, obesity, intestinal inflammatory diseases and liver fibrosis. In this review we summarize recent advances on remarkable metabolic and regulatory versatility of PXR, and we emphasizes its role and potential implication as an effective modulator of self-detoxification in animals and humans.
Similar content being viewed by others
References
Austin G, Holcroft A, Rinne N, Wang LH, Clark RE (2015) Evidence that the pregnane X and retinoid receptors PXR, RAR and RXR may regulate transcription of the transporter hOCT1 in chronic myeloid leukaemia cells. Eur J Haematol 94:74–78. doi:10.1111/Ejh.12409
Azuma K, Casey SC, Urano T, Horie-Inoue K, Ouchi Y, Blumberg B, Inoue S (2015) Pregnane X receptor knockout mice display aging-dependent wearing of articular cartilage. PLoS One 10:e0119177. doi:10.1371/journal.pone.0119177
Beigneux AP, Moser AH, Shigenaga JK, Grunfeld C, Feingold KR (2002) Reduction in cytochrome P-450 enzyme expression is associated with repression of CAR (constitutive androstane receptor) and PXR (pregnane X receptor) in mouse liver during the acute phase response. Biochem Biophys Res Commun 293:145–149. doi:10.1016/S0006-291x(02)00196-1
Biswas A, Pasquel D, Tyagi RK, Mani S (2011) Acetylation of pregnane X receptor protein determines selective function independent of ligand activation. Biochem Biophys Res Commun 406:371–376. doi:10.1016/j.bbrc.2011.02.048
Blumberg B, Sabbagh W, Juguilon H, Bolado J, van Meter CM, Ono ES, Evans RM (1998) SXR, a novel steroid and xenobiotic-sensing nuclear receptor. Gene Dev 12:3195–3205. doi:10.1101/gad.12.20.3195
Brandl K, Schnabl B (2015) Is intestinal inflammation linking dysbiosis to gut barrier dysfunction during liver disease? Expert Rev Gastroenterol 9:1069–1076. doi:10.1586/17474124.2015.1057122
Buler M, Aatsinki SM, Skoumal R, Hakkola J (2011) Energy sensing factors PGC-1 alpha and SIRT1 modulate PXR expression and function. Biochem Pharmacol 82:2008–2015. doi:10.1016/j.bcp.2011.09.006
Buler M et al (2012) Energy-sensing factors coactivator peroxisome proliferator-activated receptor gamma coactivator 1-alpha (PGC-1alpha) and AMP-activated protein kinase control expression of inflammatory mediators in liver: induction of interleukin 1 receptor antagonist. J Biol Chem 287:1847–1860. doi:10.1074/jbc.M111.302356
Cantwell B, McBride AJ (1998) Self detoxification by amphetamine dependent patients: a pilot study. Drug Alcohol Depend 49:157–163. doi:10.1016/S0376-8716(97)00160-9
Carazo A et al (2017) Acetylated deoxycholic (DCA) and cholic (CA) acids are potent ligands of pregnane X (PXR) receptor. Toxicol Lett 265:86–96. doi:10.1016/j.toxlet.2016.11.013
Cave MC et al (2016) Nuclear receptors and nonalcoholic fatty liver diseases. BBA-Gene Regul Mech 1859:1083–1099. doi:10.1016/j.bbagrm.2016.03.002
Cecchin E, De Mattia E, Toffoli G (2016) Nuclear receptors and drug metabolism for the personalization of cancer therapy. Expert Opin Drug Metab 12:291–306. doi:10.1517/17425255.2016.1141196
Chen TS (2008) Nuclear receptor drug discovery. Curr Opin Chem Biol 12:418–426. doi:10.1016/j.cbpa.2008.07.001
Chen Y, Tang Y, Wang MT, Zeng S, Nie D (2007) Human pregnane X receptor and resistance to chemotherapy in prostate cancer. Can Res 67:10361–10367. doi:10.1158/0008-5472.CAN-06-4758
Cheng J, Shah YM, Gonzalez FJ (2012) Pregnane X receptor as a target for treatment of inflammatory bowel disorders. Trends Pharmacol Sci 33:323–330. doi:10.1016/j.tips.2012.03.003
Chiang TS et al (2014) Higher expression of cytochrome P450 3A4 in human mesenchymal and adipose-derived stem cells than in dermal fibroblasts: with emphasis on the correlation with basal pregnane X receptor expression. Process Biochem 49:1983–1989. doi:10.1016/j.procbio.2014.08.006
Ding XS, Staudinger JL (2005a) Induction of drug metabolism by forskolin: the role of the pregnane X receptor and the protein kinase A signal transduction pathway. J Pharmacol Exp Ther 312:849–856. doi:10.1124/jpet.104.076331
Ding XS, Staudinger JL (2005b) Repression of PXR-mediated induction of hepatic CYP3A gene expression by protein kinase C. Biochem Pharmacol 69:867–873. doi:10.1016/j.bcp.2004.11.025
Dixit V, Moore A, Tsao H, Hariparsad N (2016) Application of micropatterned cocultured hepatocytes to evaluate the inductive potential and degradation rate of major xenobiotic metabolizing enzymes. Drug Metab Dispos 44:250–261. doi:10.1124/dmd.115.067173
Dong HY, Curran I, Williams A, Bondy G, Yauk CL, Wade MG (2016) Hepatic miRNA profiles and thyroid hormone homeostasis in rats exposed to dietary potassium perfluorooctanesulfonate (PFOS). Environ Toxicol Pharmacol 41:201–210. doi:10.1016/j.etap.2015.12.009
Dou W et al (2014) Plant flavonol isorhamnetin attenuates chemically induced inflammatory bowel disease via a PXR-dependent pathway. J Nutr Biochem 25:923–933. doi:10.1016/j.jnutbio.2014.04.006
Dussault I, Forman BM (2002) The nuclear receptor PXR: a master regulator of “homeland” defense. Crit Rev Eukaryot Gene 12:53–64. doi:10.1615/CritRevEukaryotGeneExpr.v12.i1.30
Elton L, Carpentier I, Verhelst K, Staal J, Beyaert R (2015) The multifaceted role of the E3 ubiquitin ligase HOIL-1: beyond linear ubiquitination. Immunol Rev 266:208–221. doi:10.1111/imr.12307
Esposito G et al (2016) Rifaximin improves Clostridium difficile toxin A-induced toxicity in Caco-2 cells by the PXR-dependent TLR4/MyD88/NF-kappaB pathway. Front Pharmacol 7:120. doi:10.3389/fphar.2016.00120
Fuchs CD, Traussnigg SA, Trauner M (2016) Nuclear receptor modulation for the treatment of nonalcoholic fatty liver disease. Semin Liver Dis 36:69–86. doi:10.1055/s-0036-1571296
Gao J, Xie W (2010) Pregnane X receptor and constitutive androstane receptor at the crossroads of drug metabolism and energy metabolism. Drug Metab Dispos 38:2091–2095. doi:10.1124/dmd.110.035568
Garg A et al (2016) Pregnane X receptor activation attenuates inflammation-associated intestinal epithelial barrier dysfunction by inhibiting cytokine-induced myosin light-chain kinase expression and c-Jun N-terminal kinase 1/2 activation. J Pharmacol Exp Ther 359:91–101. doi:10.1124/jpet.116.234096
Gu LY et al (2006) Role of receptor for advanced glycation end-products and signalling events in advanced glycation end-product-induced monocyte chemoattractant protein-1 expression in differentiated mouse podocytes. Nephrol Dial Transpl 21:299–313. doi:10.1093/Ndt/Gfi210
Gupta D et al (2008) Expanding the roles for pregnane X receptor in cancer: proliferation and drug resistance in ovarian cancer. Clin Cancer Res 14:5332–5340. doi:10.1158/1078-0432.CCR-08-1033
Harvey JL, Paine AJ, Maurel P, Wright MC (2000) Effect of the adrenal 11-beta-hydroxylase inhibitor metyrapone on human hepatic cytochrome P-450 expression: induction of cytochrome Pp-450 3A4. Drug Metab Dispos 28:96–101
Haughton EL et al (2006) Pregnane X receptor activators inhibit human hepatic stellate cell transdifferentiation in vitro. Gastroenterology 131:194–209. doi:10.1053/j.gastro.2006.04.012
He JH, Nishida S, Xu MS, Makishima M, Xie W (2011) PXR prevents cholesterol gallstone disease by regulating biosynthesis and transport of bile salts. Gastroenterology 140:2095–2106. doi:10.1053/j.gastro.2011.02.055
He LQ et al (2017a) AMPK/alpha-ketoglutarate axis regulates intestinal water and ion homeostasis in young pigs. J Agric Food Chem 65:2287–2298. doi:10.1021/acs.jafc.7b00324
He LQ et al (2017b) Alpha-ketoglutarate suppresses the NF-κB-mediated inflammatory pathway and enhances the PXR-regulated detoxification pathway. Oncotarget. doi:10.18632/oncotarget.16875
Holmstock N, Gonzalez FJ, Baes M, Annaert P, Augustijns P (2013) PXR/CYP3A4-humanized mice for studying drug-drug interactions involving intestinal P-glycoprotein. Mol Pharm 10:1056–1062. doi:10.1021/mp300512r
Hu G, Xu CS, Staudinger JL (2010) Pregnane X receptor is SUMOylated to repress the inflammatory response. J Pharmacol Exp Ther 335:342–350. doi:10.1124/jpet.110.171744
Hukkanen J, Hakkola J, Rysa J (2014) Pregnane X receptor (PXR)—a contributor to the diabetes epidemic? Drug Metab Drug Interact 29:3–15. doi:10.1515/dmdi-2013-0036
Igarashi M, Yogiashi Y, Mihara M, Takada I, Kitagawa H, Kato S (2007) Vitamin K induces osteoblast differentiation through pregnane X receptor-mediated transcriptional control of the Msx2 gene (Retracted article. See vol. 34, pg. 918, 2014). Mol Cell Biol 27:7947–7954. doi:10.1128/Mcb.00813-07
Ikarashi N et al (2017) Epigallocatechin gallate induces a hepatospecific decrease in the CYP3A expression level by altering intestinal flora. Eur J Pharm Sci 100:211–218. doi:10.1016/j.ejps.2017.01.022
Iwamoto J, Saito Y, Honda A, Miyazaki T, Ikegami T, Matsuzaki Y (2013) Bile acid malabsorption deactivates pregnane X receptor in patients with Crohn’s disease. Inflamm Bowel Dis 19:1278–1284. doi:10.1097/Mib.0b013e318281f423
Johnson DR, Li CW, Chen LY, Ghosh JC, Chen JD (2006) Regulation and binding of pregnane X receptor by nuclear receptor corepressor silencing mediator of retinoid and thyroid hormone receptors (SMRT). Mol Pharmacol 69:99–108. doi:10.1124/mol.105.013375
Jones SA, Moore LB, Wisely GB, Kliewer SA (2002) Use of in vitro pregnane X receptor assays to assess CYP3A4 induction potential of drug candidates. Method Enzymol 357:161–170
Kast HR et al (2002) Regulation of multidrug resistance-associated protein 2 (ABCC2) by nuclear receptors pregnane X receptor, farnesoid X-activated receptor, and constitutive androstane receptor. J Biol Chem 277:2908–2915. doi:10.1074/jbc.M109326200
Kliewer SA, Goodwin B, Willson TM (2002) The nuclear pregnane X receptor: a key regulator of xenobiotic metabolism. Endocr Rev 23:687–702. doi:10.1210/Er.2001.0038
Kodama S, Moore R, Yamamoto Y, Negishi M (2007) Human nuclear pregnane X receptor cross-talk with CREB to repress cAMP activation of the glucose-6-phosphatase gene. Biochem J 407:373–381. doi:10.1042/BJ20070481
Kubota A, Goldstone JV, Lemaire B, Takata M, Woodin BR, Stegeman JJ (2015) Role of pregnane X receptor and aryl hydrocarbon receptor in transcriptional regulation of pxr, CYP2, and CYP3 genes in developing zebrafish. Toxicol Sci 143:398–407. doi:10.1093/toxsci/kfu240
Li T, Yu RT, Atkins AR, Downes M, Tukey RH, Evans RM (2012) Targeting the pregnane X receptor in liver injury. Expert Opin Ther Targets 16:1075–1083. doi:10.1517/14728222.2012.715634
Lichti-Kaiser K, Xu CS, Staudinger JL (2009) Cyclic AMP-dependent protein kinase signaling modulates pregnane X receptor activity in a species-specific manner. J Biol Chem 284:6639–6649. doi:10.1074/jbc.M807426200
Ma X, Chen JS, Tian YA (2015) Pregnane X receptor as the “sensor and effector” in regulating epigenome. J Cell Physiol 230:752–757. doi:10.1002/Jcp.24838
Masuyama H, Hiramatsu Y, Kunitomi M, Kudo T, MacDonald PN (2000) Endocrine disrupting chemicals, phthalic acid and nonylphenol, activate pregnane X receptor-mediated transcription. Mol Endocrinol 14:421–428. doi:10.1210/Me.14.3.421
Noll EM et al (2016) CYP3A5 mediates basal and acquired therapy resistance in different subtypes of pancreatic ductal adenocarcinoma. Nat Med 22:278–287. doi:10.1038/nm.4038
Orr JG et al (2004) Mechanism of action of the antifibrogenic compound gliotoxin in rat liver cells. Hepatology 40:232–242. doi:10.1002/Hep.20254
Pondugula SR, Brimer-Cline C, Wu J, Schuetz EG, Tyagi RK, Chen TS (2009a) A phosphomimetic mutation at threonine-57 abolishes transactivation activity and alters nuclear localization pattern of human pregnane X receptor. Drug Metab Dispos 37:719–730. doi:10.1124/dmd.108.024695
Pondugula SR, Dong HQ, Chen TS (2009b) Phosphorylation and protein–protein interactions in PXR-mediated CYP3A repression. Expert Opin Drug Metab 5:861–873. doi:10.1517/17425250903012360
Priyanka Kotiya D, Rana M, Subbarao N, Puri N, Tyagi RK (2016) Transcription regulation of nuclear receptor PXR: role of SUMO-1 modification and NDSM in receptor function. Mol Cell Endocrinol 420:194–207. doi:10.1016/j.mce.2015.11.001
Rana R, Coulter S, Kinyamu H, Goldstein JA (2013) RBCK1, an E3 ubiquitin ligase, interacts with and ubiquinates the human pregnane X receptor. Drug Metab Dispos 41:398–405. doi:10.1124/dmd.112.048728
Robbins D, Chen TS (2014) Tissue-specific regulation of pregnane X receptor in cancer development and therapy. Cell Biosci. doi:10.1186/2045-3701-4-17
Schmuth M, Moosbrugger-Martinz V, Blunder S, Dubrac S (2014) Role of PPAR, LXR, and PXR in epidermal homeostasis and inflammation. BBA-Mol Cell Biol Lipids 1841:463–473. doi:10.1016/j.bbalip.2013.11.012
Schupp M, Lazar MA (2010) Endogenous ligands for nuclear receptors: digging deeper. J Biol Chem 285:40409–40415. doi:10.1074/jbc.R110.182451
Shah YM, Ma XC, Morimura K, Kim I, Gonzalez FJ (2007) Pregnane X receptor activation ameliorates DSS-induced inflammatory bowel disease via inhibition of NF-kappa B target gene expression. Am J Physiol-Gastrointest Liver 292:G1114–G1122. doi:10.1152/ajpgi.00528.2006
Shehu AI, Li GM, Xie W, Ma XC (2016) The pregnane X receptor in tuberculosis therapeutics. Expert Opin Drug Metab 12:21–30. doi:10.1517/17425255.2016.1121381
Skowronek R, Czekaj P, Suszka-Switek A, Czech E, Wiaderkiewicz A, Plewka D, Bryzek A (2016) Expression of cytochrome P450 2c and 3a in female rat liver after long-term administration of gonadoliberin analogs. Int J Occup Med Environ 29:293–314
Smutny T, Mani S, Pavek P (2013) Post-translational and post-transcriptional modifications of pregnane X receptor (PXR) in regulation of the cytochrome P450 superfamily. Curr Drug Metab 14:1059–1069
Sonoda J, Rosenfeld JM, Xu L, Evans RM, Xie W (2003) A nuclear receptor-mediated xenobiotic response and its implication in drug metabolism and host protection. Curr Drug Metab 4:59–72. doi:10.2174/1389200033336739
Spruiell K, Richardson RM, Cullen JM, Awumey EM, Gonzalez FJ, Gyamfi MA (2014) Role of pregnane X receptor in obesity and glucose homeostasis in male mice. J Biol Chem 289:3244–3261. doi:10.1074/jbc.M113.494575
Staudinger JL et al (2001) The nuclear receptor PXR is a lithocholic acid sensor that protects against liver toxicity. Proc Natl Acad Sci USA 98:3369–3374. doi:10.1073/pnas.051551698
Staudinger JL, Xu CS, Biswas A, Mani S (2011) Post-translational modification of pregnane X receptor. Pharmacol Res 64:4–10. doi:10.1016/j.phrs.2011.02.011
Staudinger JL, Woody S, Sun MX, Cui WQ (2013) Nuclear-receptor-mediated regulation of drug- and bile-acid-transporter proteins in gut and liver. Drug Metab Rev 45:48–59. doi:10.3109/03602532.2012.748793
Stedman CA et al (2005) Nuclear receptors constitutive androstane receptor and pregnane X receptor ameliorate cholestatic liver injury. Proc Natl Acad Sci USA 102:2063–2068. doi:10.1073/pnas.0409794102
Tan HS et al (2016) SUMOylation of pregnane X receptor suppresses rifampicin-induced CYP3A4 and P-gp expression and activity in LS174T cells. J Pharmacol Sci 130:66–71. doi:10.1016/j.jphs.2015.11.006
Taniki N et al (2015) The gut-liver axis coordinate T-cell-mediated immunity by regulating the antigen-presenting activity of macrophages in murine liver. Hepatology 62:1245a–1245a
Terc J, Hansen A, Alston L, Hirota SA (2014) Pregnane X receptor agonists enhance intestinal epithelial wound healing and repair of the intestinal barrier following the induction of experimental colitis. Eur J Pharm Sci 55:12–19. doi:10.1016/j.ejps.2014.01.007
Treuter E, Venteclef N (2011) Transcriptional control of metabolic and inflammatory pathways by nuclear receptor SUMOylation. Biochem Biophys Acta 1812:909–918. doi:10.1016/j.bbadis.2010.12.008
Wada T, Gao J, Xie W (2009) PXR and CAR in energy metabolism. Trends Endocrinol Metab 20:273–279. doi:10.1016/j.tem.2009.03.003
Wahlang B et al (2016) Polychlorinated biphenyl-xenobiotic nuclear receptor interactions regulate energy metabolism, behavior, and inflammation in non-alcoholic-steatohepatitis. Toxicol Sci 149:396–410. doi:10.1093/toxsci/kfv250
Wallace K et al (2010) The PXR is a drug target for chronic inflammatory liver disease. J Steroid Biochem 120:137–148. doi:10.1016/j.jsbmb.2010.04.012
Xie YQ et al (2016) Pregnane receptor gene polymorphisms, pathogenic bacteria distribution and drug sensitivity, and TCM syndrome differentiation in patients with cholelithiasis. Asian Pac J Trop Med 9:301–305. doi:10.1016/j.apjtm.2016.03.001
Ye NH, Wang H, Hong J, Zhang T, Lin CT, Meng C (2016) PXR mediated protection against liver inflammation by ginkgolide a in tetrachloromethane treated mice. Biomol Ther 24:40–48. doi:10.4062/biomolther.2015.077
Zeng H et al (2016) Hepatoprotective effects of schisandra sphenanthera extract against lithocholic acid-induced cholestasis in male mice are associated with activation of the pregnane X receptor pathway and promotion of liver regeneration. Drug Metab Dispos 44:337–342. doi:10.1124/dmd.115.066969
Zhai YG, Pai HV, Zhou J, Amico JA, Vollmer RR, Xie W (2007) Activation of pregnane X receptor disrupts glucocorticoid and mineralocorticoid homeostasis. Mol Endocrinol 21:138–147. doi:10.1210/Me.2006-0291
Zhang J et al (2015) Notoginsenoside R1 attenuates experimental inflammatory bowel disease via pregnane X receptor activation. J Pharmacol Exp Ther 352:315–324. doi:10.1124/jpet.114.218750
Zhao JD et al (2016) Cross-talk between EPAS-1/HIF-2 alpha and PXR signaling pathway regulates multi-drug resistance of stomach cancer cell. Int J Biochem Cell B 72:73–88. doi:10.1016/j.biocel.2016.01.006
Zhou C et al (2006) Mutual repression between steroid and xenobiotic receptor and NF-kappa B signaling pathways links xenobiotic metabolism and inflammation. J Clin Investig 116:2280–2289. doi:10.1172/Jci26283
Zhou T et al (2016) Ginkgolide B protects human umbilical vein endothelial cells against xenobiotic injuries via PXR activation. Acta Pharmacol Sin 37:177–186. doi:10.1038/aps.2015.124
Acknowledgements
This study was supported by Hunan Outstanding Young Scholars Foundation (2016JJ1015), National Basic Research Program of China (2013CB127301, 2013CB127306), the National Natural Science Foundation Project (31472107), the Chinese Academy of Sciences “Hundred Talent” award, and the Open Foundation of Key Laboratory of Agro-ecological Processes in Subtropical Region, Institute of Subtropical Agriculture, Chinese Academy of Sciences (ISA2016101), National Science and Technology Support Project (2013BAD21B04), and National Natural Science Foundation of China (31472106). Chinese Academy of Sciences visiting professorship for senior international scientists Grant (2016VBB007).
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Ethical statement
All experimental procedures were approved by the Institutional Animal Care and Use Committee at Institute of Subtropical Agriculture, The Chinese Academy of Sciences.
Additional information
Handling Editors: C.-A. A. Hu, Y. Yin, Y. Hou, G. Wu, Y. Teng.
Rights and permissions
About this article
Cite this article
He, L., Zhou, X., Huang, N. et al. Functions of pregnane X receptor in self-detoxification. Amino Acids 49, 1999–2007 (2017). https://doi.org/10.1007/s00726-017-2435-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00726-017-2435-0